Clinical Course and Features of Seizures Associated With LGI1-Antibody Encephalitis
- 14 September 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 97 (11), E1141-E1149
- https://doi.org/10.1212/wnl.0000000000012465
Abstract
Objective: To determine risk factors associated with clinical relapses and development of chronic epilepsy in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) IgG encephalitis. Methods: Patients with seizures related to LGI1-antibody encephalitis with ≥ 24 months of follow-up from disease onset were identified in the Mayo Clinic electronic medical record and Neuroimmunology lab records. Charts were reviewed to determine clinical factors, seizure types, imaging, treatment, occurrence of relapse, and outcome. Binary logistic regression analysis was performed to identify predictors of the development of chronic epilepsy. Univariate Cox proportional hazards regression was used to examine the influence of baseline characteristics on relapse risk. Results: Forty-nine patients with LGI1-antibody encephalitis and acute symptomatic seizures were identified. Almost all patients (n=48, 98%) were treated with immunotherapy. Eight had definite, and two had possible chronic epilepsy at last follow-up (10/49, 20.4%). Female sex (P=0.048) and younger age at disease onset (P=0.02) were associated with development of chronic epilepsy. Relapses occurred in 20 (40.8%), with a median time to first relapse of 7.5 months (range 3-94 months). Initial treatment with chronic steroid sparing immunotherapy was associated with reduced risk of relapse (hazards ratio=0.28, 95% CI 0.11-0.73, P=0.009). Conclusions: Chronic epilepsy occurred in 20.4% of our patients with LGI1-antibody encephalitis despite aggressive immunotherapy. Risk factors for chronic epilepsy were female sex and earlier age of onset. Relapses occurred in 40.8% of patients with prolonged follow-up, and chronic steroid sparing immunotherapy was associated with a lower relapse rate.This publication has 41 references indexed in Scilit:
- Pilomotor seizures: An autonomic semiology of limbic encephalitis?Seizure, 2014
- ILAE Official Report: A practical clinical definition of epilepsyEpilepsia, 2014
- Autoimmune encephalitis updateNeuro-Oncology, 2014
- MRI Findings in Autoimmune Voltage-Gated Potassium Channel Complex Encephalitis with Seizures: One Potential Etiology for Mesial Temporal SclerosisAmerican Journal Of Neuroradiology, 2013
- Insights From LGI1 and CASPR2 Potassium Channel Complex Autoantibody SubtypingJAMA Neurology, 2013
- Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitisAnnals of Neurology, 2010
- An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitisJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Cross-sensitivity of skin rashes with antiepileptic drug useNeurology, 2008
- Comparison and predictors of rash associated with 15 antiepileptic drugsNeurology, 2007
- Localising and lateralising value of ictal piloerectionJournal of Neurology, Neurosurgery & Psychiatry, 2004